[Diagnostics of mucopolysaccharidoses presented through the case of Sanfilippo syndrome]

Insights

Mucopolysaccharidoses (MPS) are rare genetic disorders. This case study identifies Mucopolysaccharidosis type A (MPS III) in a child with developmental delays and physical abnormalities, highlighting diagnostic challenges.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Mucopolysaccharidoses (MPS) are inherited metabolic disorders characterized by the lysosomal accumulation of glycosaminoglycans.
  • These progressive diseases result from deficiencies in specific lysosomal enzymes responsible for glycosaminoglycan degradation.

Observation:

  • A five-year-old boy presented with psychomotor retardation, distinctive facial features, skeletal deformities, and hepatosplenomegaly.
  • Radiographic examination confirmed Dysostosis epiphysealis multiplex, and he exhibited moderate intellectual disability (IQ 48).

Findings:

  • Metabolic screening revealed increased urinary glycosaminoglycan excretion, confirmed by a positive toluidine blue test.
  • Enzyme analysis identified a deficiency in heparin sulfate sulfatase, leading to the diagnosis of Mucopolysaccharidosis type A (Sanfilippo syndrome).

Implications:

  • The genetic heterogeneity of MPS poses challenges for molecular diagnostics and carrier identification.
  • Prenatal diagnosis via chorionic villus sampling was recommended for subsequent pregnancies.
  • The patient's prognosis is poor, with expected mortality in the second decade due to progressive neurological decline.